1. Home
  2. LRMR vs UTMD Comparison

LRMR vs UTMD Comparison

Compare LRMR & UTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRMR
  • UTMD
  • Stock Information
  • Founded
  • LRMR N/A
  • UTMD 1978
  • Country
  • LRMR United States
  • UTMD United States
  • Employees
  • LRMR N/A
  • UTMD N/A
  • Industry
  • LRMR Biotechnology: Pharmaceutical Preparations
  • UTMD Medical/Dental Instruments
  • Sector
  • LRMR Health Care
  • UTMD Health Care
  • Exchange
  • LRMR Nasdaq
  • UTMD Nasdaq
  • Market Cap
  • LRMR 191.4M
  • UTMD 178.8M
  • IPO Year
  • LRMR N/A
  • UTMD N/A
  • Fundamental
  • Price
  • LRMR $3.09
  • UTMD $58.44
  • Analyst Decision
  • LRMR Strong Buy
  • UTMD
  • Analyst Count
  • LRMR 7
  • UTMD 0
  • Target Price
  • LRMR $17.86
  • UTMD N/A
  • AVG Volume (30 Days)
  • LRMR 1.4M
  • UTMD 21.2K
  • Earning Date
  • LRMR 08-06-2025
  • UTMD 07-24-2025
  • Dividend Yield
  • LRMR N/A
  • UTMD 2.09%
  • EPS Growth
  • LRMR N/A
  • UTMD N/A
  • EPS
  • LRMR N/A
  • UTMD 3.78
  • Revenue
  • LRMR N/A
  • UTMD $39,273,000.00
  • Revenue This Year
  • LRMR N/A
  • UTMD N/A
  • Revenue Next Year
  • LRMR N/A
  • UTMD N/A
  • P/E Ratio
  • LRMR N/A
  • UTMD $15.45
  • Revenue Growth
  • LRMR N/A
  • UTMD N/A
  • 52 Week Low
  • LRMR $1.61
  • UTMD $51.26
  • 52 Week High
  • LRMR $11.20
  • UTMD $77.33
  • Technical
  • Relative Strength Index (RSI)
  • LRMR 60.78
  • UTMD 63.53
  • Support Level
  • LRMR $2.81
  • UTMD $54.44
  • Resistance Level
  • LRMR $3.19
  • UTMD $58.00
  • Average True Range (ATR)
  • LRMR 0.30
  • UTMD 1.37
  • MACD
  • LRMR 0.01
  • UTMD 0.23
  • Stochastic Oscillator
  • LRMR 82.43
  • UTMD 99.33

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

About UTMD Utah Medical Products Inc.

Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.

Share on Social Networks: